Clinical trials
Completed COVID-19 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
172 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 54 |
| 2021 | 38 |
| 2022 | 46 |
| 2023 | 28 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 172 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sinovac Research and Development Co., Ltd. | 11 |
| Jiangsu Province Centers for Disease Control and Prevention | 10 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 6 |
| CanSino Biologics Inc. | 6 |
| Sinovac Life Sciences Co., Ltd. | 5 |
| Brii Biosciences Limited | 4 |
| Huahui Health | 4 |
| RenJi Hospital | 4 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Southeast University, China | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 172 |
| Coronavirus Infections | 8 |
| Postoperative Complications | 5 |
| Anxiety Disorders | 3 |
| Infections | 3 |
| Influenza, Human | 3 |
| Pneumonia | 3 |
| Coinfection | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Respiratory Distress Syndrome | 2 |
Trials
Showing 1 to 25 of 172. Each trial links to its page on Pharma Observatory.
72 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.